Skip to main content
Google Tag Manager
P&T COMMUNITY
Register
Sign in
Search form
Search
News
Approvals, Launches, & New Indications
Pipeline Plus
Research News
Industry Trends
Safety Issues
Agency Actions
Health Care Reform
Guidelines
Clinical Trials
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Reports
Health Care & Law
Drug Forecast
More
Meeting Highlights
Medication Errors
Prescription: Washington
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
JAKAFI®
ruxolitinib (tablets)
PERSERIS™
(risperidone) for extended-release injectable suspension
ZULRESSO™
(brexanolone) injection CIV
You are here
Home
News by month %2 2005
News by month September 2005
PTCommunity News September 2005
StaphVAX Immunogenicity Study in Orthopedic Patients Meets Primary Endpoints of Safety and Immune Response
Atorvastatin Approval Includes Reduction in the Risk of Stroke, Heart Attack in Diabetes
NIAID, MedImmune Agree To Develop Avian Flu Vaccines
Expanded Label Sought for Ramipril in Chronic Kidney Disease in Hypertensive Patients
Favorable Orphan Medicinal Product Status Granted for Altastaph in Europe
Patient Enrollment Initiated for Phase 3 Clinical Trial of Miraxion in Huntington's Disease
FDA Grants MC-1 Fast Track Designation
NIMH Study To Guide Treatment Choices for Schizophrenia
FDA Approves Infliximab To Treat Ulcerative Colitis
Concerns With Safety Halt Phase 2 Trial of Alemtuzumab
European Advisory Panel Recommends Approval of Age-Related Blindness Treatment Macugen
Fourth Phase 3 Study Shows Herceptin Plus Chemotherapy Improved Disease- Free Survival in Early-Stage HER2-Positive Breast Cancer
Budesonide Provides Lasting Relief for Patients With Crohn's Disease
Special Protocol Assessment for Miraxion in Huntington's Disease Cleared by FDA
PROactive Study Shows That Pioglitazone Reduced Heart Attacks, Strokes and Deaths
FDA Tentatively Approves Generic Zidovudine Oral Solution
Combination Vaccine for Measles, Mumps, Rubella, and Varicella Gains FDA Nod